ProQR Therapeutics N.V. Ordinary Shares (PRQR) is a publicly traded Healthcare sector company. As of May 21, 2026, PRQR trades at $1.51 with a market cap of $159.10M and a P/E ratio of 0.00. PRQR moved +0.00% today. Year to date, PRQR is -29.90%; over the trailing twelve months it is -18.75%. Its 52-week range spans $1.07 to $4.62. Analyst consensus is strong buy with an average price target of $8.20. Rallies surfaces PRQR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What do analysts rate PRQR?
5 analysts cover PRQR: 0 strong buy, 5 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $8.20.